Correlation Between Stoke Therapeutics and Edgewise Therapeutics
Can any of the company-specific risk be diversified away by investing in both Stoke Therapeutics and Edgewise Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Stoke Therapeutics and Edgewise Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Stoke Therapeutics and Edgewise Therapeutics, you can compare the effects of market volatilities on Stoke Therapeutics and Edgewise Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Stoke Therapeutics with a short position of Edgewise Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Stoke Therapeutics and Edgewise Therapeutics.
Diversification Opportunities for Stoke Therapeutics and Edgewise Therapeutics
-0.64 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Stoke and Edgewise is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding Stoke Therapeutics and Edgewise Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Edgewise Therapeutics and Stoke Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Stoke Therapeutics are associated (or correlated) with Edgewise Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Edgewise Therapeutics has no effect on the direction of Stoke Therapeutics i.e., Stoke Therapeutics and Edgewise Therapeutics go up and down completely randomly.
Pair Corralation between Stoke Therapeutics and Edgewise Therapeutics
Given the investment horizon of 90 days Stoke Therapeutics is expected to under-perform the Edgewise Therapeutics. In addition to that, Stoke Therapeutics is 1.41 times more volatile than Edgewise Therapeutics. It trades about -0.08 of its total potential returns per unit of risk. Edgewise Therapeutics is currently generating about -0.11 per unit of volatility. If you would invest 3,404 in Edgewise Therapeutics on August 27, 2024 and sell it today you would lose (206.00) from holding Edgewise Therapeutics or give up 6.05% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Stoke Therapeutics vs. Edgewise Therapeutics
Performance |
| Timeline |
| Stoke Therapeutics |
| Edgewise Therapeutics |
Stoke Therapeutics and Edgewise Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Stoke Therapeutics and Edgewise Therapeutics
The main advantage of trading using opposite Stoke Therapeutics and Edgewise Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Stoke Therapeutics position performs unexpectedly, Edgewise Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edgewise Therapeutics will offset losses from the drop in Edgewise Therapeutics' long position.| Stoke Therapeutics vs. Adaptimmune Therapeutics Plc | Stoke Therapeutics vs. Black Diamond Therapeutics | Stoke Therapeutics vs. Relay Therapeutics | Stoke Therapeutics vs. Pliant Therapeutics |
| Edgewise Therapeutics vs. Century Therapeutics | Edgewise Therapeutics vs. C4 Therapeutics | Edgewise Therapeutics vs. Mineralys Therapeutics, Common | Edgewise Therapeutics vs. Cullinan Oncology LLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |